Table 1

Baseline Characteristics of Patients

Placebo (n = 984)Carvedilol (n = 975)
Mean (range) age (yrs)63 (25–90)63 (29–88)
Males (%)7473
Past medical history (%)*
 Diabetes mellitus2321
 Coronary revascularization1112
 Atrial fibrillation/flutter98
 Ventricular fibrillation1.40.6
Site of AMI (%)
Treatment for index AMI (%)
 Thrombolysis/primary PCI4745
 Intravenous diuretic3335
Medication at randomization (%)
 Other antiarrhythmic drug<10
 ACE inhibitor9798

ACE = angiotensin-converting enzyme; AMI = acute myocardial infarction; MI = myocardial infarction; PCI = percutaneous coronary intervention.

  • * Past or ongoing.